×
About 403,615 results

Calise & Sons Bakery, Inc. Recalls Golden Flax Scala Bread Because of Possible Health Risk
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/449628

On 11/23 Calise & Sons Bakery, Inc. produced Italian Scala Bread (Italian bread w/Sesame Seeds) and by error were packaged in a bag that says Golden Flax Seed Scala Bread, photos below. A total of 689 packages were produced that went out to markets in RI, MA, NH and CT. The packages have a white p

Alsum Farms & Produce Voluntarily Recalls Select Yellow, White, and Red Onions Because of Possible Health Risk
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/436724

Friesland, Wisconsin, November 12, 2021 - Alsum Farms & Produce, Inc. of Friesland, Wisconsin is voluntarily recalling Alsum Farms & Produce fresh whole yellow onions in 3 lb. bags, 5 lb. bags, and 50 lb. cartons; fresh whole white onions in 2 lb. bags; and fresh whole red onions in 2 lb. bags deliv

Clinical Edge Journal Scan Commentary: RA December 2021
https://www.mdedge.com/rheumatology/article/249460/rheumatoid-arthritis/clinical-edge-journal-scan-commentary-ra-december
Arundathi Jayatilleke, MD

Dec 4th, 2021 - Arundathi Jayatilleke, MD Many people with rheumatoid arthritis (RA) have concomitant hand osteoarthritis (OA). This Swiss cohort study by Lechtenboehmer et al 1 using a longitudinal registry of RA patients examined characteristics of RA patients who had progression of radiographic hand OA.

Clinical Edge Journal Scan Commentary: PsA December 2021
https://www.mdedge.com/rheumatology/article/249458/psoriatic-arthritis/clinical-edge-journal-scan-commentary-psa-december
Vinod Chandran, MBBS, MD, DM, PhD

Dec 4th, 2021 - Vinod Chandran, MBBS, MD, DM, PhD Research published in November has provided us with insights on the impact of psoriatic arthritis (PsA) as well as treatment outcomes. Although PsA often affects women of child-bearing age, data on pregnancy outcomes in PsA is scarce.

Clinical Edge Journal Scan Commentary: CAP December 2021
https://www.mdedge.com/chestphysician/article/249456/community-acquired-pneumonia/clinical-edge-journal-scan-commentary-cap

Dec 4th, 2021 - Although the majority of acute pneumonias are viral in etiology, standard practice dictates empiric administration of antimicrobial agents for the youngest, oldest, and patients with underlying comorbid conditions. The practitioner’s primary responsibility is to differentiate upper respiratory tract infections from pneumonia.

BUBS Naturals is Recalling Two Lots of Fountain of Youth Collagen Powder After Firm Testing Found Milk Protein in The Product That Uses MCT Powder Oil as an Ingredient
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/455285

BUBS Naturals of Encinitas, CA is voluntarily recalling certain lots of its Fountain of Youth Formula Collagen Protein ("Fountain of Youth Product") due to undeclared milk. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they

BUBS Naturals is Recalling Two Lots of Fountain of Youth Collagen Powder After Firm Testing Found Milk Protein in The Product That Uses MCT Powder Oil as an Ingredient
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/455284

BUBS Naturals of Encinitas, CA is voluntarily recalling certain lots of its Fountain of Youth Formula Collagen Protein ("Fountain of Youth Product") due to undeclared milk. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they

FDA Approves Adjuvant Pembrolizumab for Stage IIB or IIC Melanoma Following CR
https://www.onclive.com/view/fda-approves-adjuvant-pembrolizumab-for-stage-iib-or-iic-melanoma-following-cr

Dec 4th, 2021 - The FDA has approved pembrolizumab (Keytruda) for the adjuvant treatment of adult and pediatric patients with stage IIB or IIC melanoma following complete resection (CR). The regulatory agency also expanded the indication for the immunotherapy for adjuvant use in patients with stage III melanoma following CR to include pediatric patients aged 12 yers and older. The indication for the agent's ...

FDA Grants Priority Review to Luspatercept-aamt for Non–Transfusion Dependent Beta Thalassemia
https://www.onclive.com/view/fda-grants-priority-review-to-luspatercept-aamt-for-non-transfusion-dependent-beta-thalassemia

Dec 3rd, 2021 - The FDA has granted priority review to the supplemental biologics license application (sBLA) for luspatercept-aamt (Reblozyl) for the treatment of anemia in adults with non–transfusion dependent (NTD) β-thalassemia. The European Medicines Agency has also validated the Type II variation for the agent’s use in the same indication.1 The applications were supported by safety and efficacy data yiel...

Genetic Variants of SARS-CoV-2 May Lead to False Negative Results with Molecular Tests ...
https://www.fda.gov/medical-devices/letters-health-care-providers/genetic-variants-sars-cov-2-may-lead-false-negative-results-molecular-tests-detection-sars-cov-2
MedWatch; FDA

Dec 3rd, 2021 - UPDATE: For additional information on the impact of SARS-CoV-2 viral mutations, including the latest list of authorized tests whose performance could be impacted by SARS-CoV-2 viral mutations, see SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests. January 8, 2021 The SARS-CoV-2 virus can mutate over time, resulting in genetic variation in the population of circulating viral strains. The U.S....

Clinical Edge Journal Scan Commentary: COVID-19 December 2021
https://www.mdedge.com/icymi-covid/article/249443/covid-19/clinical-edge-journal-scan-commentary-covid-19-december-2021
Nahid Bhadelia, MD, MALD

Dec 3rd, 2021 - Nahid Bhadelia, MD, MALD COVID-19 outcomes for specific populations as well as utility of therapeutics remain important research questions. A study in Lancet HIV, examined outcomes specifically for HIV positive individuals compared to their seronegative counterparts.

High Altitudes Mess With CPR Skills in Trained EMS Personnel
https://www.medpagetoday.com/emergencymedicine/emergencymedicine/96002

Dec 3rd, 2021 - High altitude hurt the quality of chest compressions from trained rescuers without them realizing it, experiments showed. At simulated altitudes of 200, 3,000, or 5,000 meters in a hypobaric chamber, helicopter EMS personnel started out with optimal chest compressions on manikins, but gradually lost both the depth in their compressions and the proper pacing of effective compressions over time, ...

The Evolving Role of Prognostic Markers for CLL in the Era of Novel Agents
https://www.onclive.com/view/the-evolving-role-of-prognostic-markers-for-cll-in-the-era-of-novel-agents

Dec 3rd, 2021 - Although the treatment armamentarium has expanded significantly for the treatment of patients with chronic lymphocytic leukemia (CLL), it remains essential for prognostic markers to be checked at diagnosis in order to help inform decisions when it comes to choosing the optimal therapy, according to Deborah M. Stephens, DO. We don't have a cure for CLL yet, so doing further research on clinic...

Dementia Tied to Resting Heart Rate
https://www.medpagetoday.com/neurology/dementia/95999

Dec 3rd, 2021 - Higher resting heart rate (RHR) was linked to greater dementia risk and faster cognitive decline independent of cardiovascular disease in a study of more than 2,000 older adults in Sweden. People with RHR of 80 bpm or higher had a 55% increased risk of developing dementia compared with people whose RHR was 60-69 bpm (adjusted HR 1.55, 95% CI 1.06-2.27), reported Yume Imahori, MD, PhD, of the Ka...

Arrow International Inc Recalls Arrow-Trerotola Over-The-Wire PTD Kit Percutaneous Thro...
https://www.fda.gov/medical-devices/medical-device-recalls/arrow-international-inc-recalls-arrow-trerotola-over-wire-ptd-kit-percutaneous-thrombolytic-device
MedWatch; FDA

Dec 3rd, 2021 - The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. The Arrow-Trerotola Over-The-Wire (PTD) Kit Percutaneous Thrombolytic Device: 7FR includes a rotatable catheter with an outer sheath and an inner cable with a self-expanding basket. The Arrow-Trerotola Percutaneous Thrombolyic Device (PTD) Catheter is used ...

Cannabis Use Climbing in Pregnancy Among People With HIV
https://www.medpagetoday.com/obgyn/pregnancy/95996

Dec 3rd, 2021 - Among pregnant people living with HIV, marijuana use climbed over the last decade both in pregnancy and during the postpartum period, according to results from a cohort study. Prevalence of marijuana use during pregnancy among people living with HIV increased from 7.1% in 2007 to 11.7% in 2019, reported Lynn Yee, MD, MPH, of Northwestern University Feinberg School of Medicine, and colleagues. D...

Update: Expansion of Recall of LeadCare Blood Lead Tests Due to Risk of Falsely Low Results - Health Alert Network (HAN) No. 457
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/454625

The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Update as an update to HAN Update 454: Expansion of Recall of LeadCare Blood Lead Tests Due to Risk of Falsely Low Results that CDC issued on October 14, 2021. The purpose of this HAN Update is to clarify options for retesting children who were tested with the recalled LeadCare lead test kits....

Omicron Creep Begins; Autism Cases Jump; States Ready Abortion Restrictions, Bans
https://www.medpagetoday.com/infectiousdisease/covid19/95989

Dec 3rd, 2021 - Note that some links may require registration or subscription. New York health officials have identified five cases of the Omicron coronavirus variant in Long Island, Queens, and Brooklyn. (Gothamist) Officials in Minnesota and Colorado announced the first cases of Omicron infection in their respective states. (Reuters, Denver Post) A confirmed Omicron case in Hawaii raised the number of affect...

Rheumatoid Arthritis Highlights From ACR 2021
https://www.mdedge.com/rheumatology/article/249124/acr-2021-rheumatoid-arthritis/rheumatoid-arthritis-highlights-acr-2021
Stanley B. Cohen, MD

Dec 3rd, 2021 - Rheumatologist Stanley B. Cohen from UT Southwestern Medical School offers insight on key findings in rheumatoid arthritis (RA) presented at ACR 2021.

Dr. Pothuri on the Challenges of POLE Testing in Endometrial Cancer
https://www.onclive.com/view/dr-pothuri-on-the-challenges-of-pole-testing-in-endometrial-cancer

Dec 2nd, 2021 - Bhavana Pothuri, MD, professor, departments of Obstetrics and Gynecology and Medicine, NYU Grossman School of Medicine, director, Gynecologic Oncology Clinical Trials, NYU Langone Health’s Perlmutter Cancer Center, discusses the challenges of DNA polymerase epsilon (POLE) mutation testing in endometrial cancer. POLE mutation testing requires tissue-based next-generation sequencing, so it ca...